Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 193 pages)

 

Export 7 results:
Author [ Title(Desc)] Type Year
Filters: Author is Weng, S. F.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
S. F. Weng, Reps, J., Kai, J., Garibaldi, J. M., and Qureshi, N., “Can machine-learning improve cardiovascular risk prediction using routine clinical data?”, PLoS One, vol. 12, p. e0174944, 2017.
M. Nowakowska, Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., Mallen, C., van Marwijk, H., Peek, N., Perera-Salazar, R., Reeves, D., Rutter, M. K., Weng, S. F., Qureshi, N., Mamas, M. A., and Kontopantelis, E., “The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort”, BMC Med, vol. 17, p. 145, 2019.
I
S. F. Weng, Kai, J., H. Neil, A., Humphries, S. E., and Qureshi, N., “Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)”, Atherosclerosis, vol. 238, pp. 336-43, 2015.
L
R. K. Akyea, Kai, J., Qureshi, N., Iyen, B., and Weng, S. F., “LDL cholesterol response to statins and future risk of cardiovascular disease”, Heart, vol. 105, pp. 1290-1291, 2019.
P
S. F. Weng, Vaz, L., Qureshi, N., and Kai, J., “Prediction of premature all-cause mortality: A prospective general population cohort study comparing machine-learning and standard epidemiological approaches”, PLoS One, vol. 14, p. e0214365, 2019.
S
R. K. Akyea, Kai, J., Qureshi, N., Iyen, B., and Weng, S. F., “Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease”, Heart, 2019.
V
S. F. Weng, Kai, J., Guha, I. N., and Qureshi, N., “The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment”, Open Heart, vol. 2, p. e000272, 2015.
[Page last reviewed 6 December 2019]